Medical Oncology

Doç. Dr. Kubilay Karaboyun

Doctor and researcher İstinye Üniversitesi Medical Park Gaziosmanpaşa İstanbul
Breast NeoplasmsLung NeoplasmsCarcinoma, Non-Small-Cell LungNeoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Breast Neoplasms 9 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 5 publications
  • Carcinoma, Non-Small-Cell Lung 3 publications
  • Neoplasms 2 publications

Person ↔ Disease

Which topics does this doctor work on?

From source

Medical areas of interest stated by the doctor on the institution profile. Source: medicalpark.com.tr.

  • Meme Kanseri
  • Akciğer Kanseri
  • Prostat Kanseri
  • Gastrointestinal sistem kanserleri
  • Ürogenital Kanserler
  • Jinekolojik kanserler
  • Moleküler onkoloji

CV

Education and experience

From source

Experience

  • Experience2014 Suluova Devlet Hastanesi Pratisyen Hekimmedicalpark.com.tr
  • 20192020 Akçakale Devlet Hastanesi Dahiliye Uzmanlığımedicalpark.com.tr
  • 20242025 Ağrı Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji Uzmanlığımedicalpark.com.tr
  • Experience2025 Bağcılar Eğitim ve Araştırma Hastanesi Tıbbi Onkoloji Uzmanlığımedicalpark.com.tr

Education

  • 20082014 Cerrahpaşa Tıp Fakültesi Lisansmedicalpark.com.tr
  • 20152019 Kartal Dr.Lütfi Kırdar EAH, Bakırköy Dr.Sadi Konuk EAH İç Hastalıkları Uzmanlıkmedicalpark.com.tr
  • 20202023 Tekirdağ Namık Kemal Üniversitesi Tıbbi Onkoloji Uzmanlıkmedicalpark.com.tr
  • Education2024 Ağrı Eğitim ve Araştırma Hastanesi Doçentlikmedicalpark.com.tr

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • SpecialtyMedical Oncologymedicalpark.com.trFrom source
  • Department name at the sourceMedikal Onkoloji (Tıbbi Onkoloji)medicalpark.com.trFrom source
  • Institutionİstinye Üniversitesi Medical Park Gaziosmanpaşamedicalpark.com.trFrom source
  • Area of workBreast NeoplasmsExtracted from 9 publications · Model version —From source
  • Publications43 publicationsOpenAlex, ORCIDFrom source
  • ORCID0000-0002-1783-8075ORCIDFrom source
  • Last synchronised4 November 2026 20:33https://www.medicalpark.com.tr/hekimler/kubilay-karaboyunmedicalpark.com.tr

Scientific work

Publications on Breast Neoplasms

43 publications

  1. Inflammatory and Nutritional Indices as Prognostic Markers in Locally Advanced Gastric Cancer Treated with Neoadjuvant FLOT: A Retrospective Multicenter Study

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072574 PMID 41976874 3 citations (Europe PMC) Open-access full textSource: OpenAlex

  2. Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization Protocols

    Research Square, 2026

    DOI 10.21203/rs.3.rs-9707882/v1 Open-access full textSource: OpenAlex

  3. Identifying high-risk groups for recurrence in endometrial cancer: The role of ESMO–ESGO–ESTRO risk classification

    Journal of Cancer Research and Therapeutics, 2026

    DOI 10.4103/jcrt.jcrt_1917_24 PMID 41910289 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  4. Survival Impact of Adjuvant Chemoradiotherapy in Resected Pancreatic Cancer

    Namık Kemal Tıp Dergisi, 2025

    DOI 10.4274/nkmj.galenos.2025.81994 Open-access full textSource: OpenAlex

  5. Comprehensive analysis of the prognostic role of laboratory indices in advanced lung cancer patients

    Asia-Pacific Journal of Clinical Oncology, 2025

    DOI 10.1111/ajco.14092 PMID 38837742 8 citations (Europe PMC) Source: ORCID

  6. The role of peripheral T lymphocyte subsets and PD-1 expression as a biomarker for neoadjuvant treatment response in breast cancer

    Medicine, 2025

    DOI 10.1097/md.0000000000044743 PMID 41029123 1 citation (Europe PMC) Open-access full textSource: ORCID

  7. Prognostic Value of Estrogen Receptor Co-activator AIB1 in Metastatic Breast Cancer Patients Treated with a Combination of Ribociclib and Letrozole

    Bratislava Medical Journal, 2025

    DOI 10.1007/s44411-025-00237-y Open-access full textSource: ORCID

  8. Expression of gamma-aminobutyric acid type A receptor subunit π and minichromosome maintenance-3 in breast cancer patients treated with neoadjuvant chemotherapy: a target molecule or a proliferation marker?

    Revista da Associação Médica Brasileira, 2025

    DOI 10.1590/1806-9282.20250507 PMID 41124552 Open-access full textSource: ORCID

  9. Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations

    Medicina, 2025

    DOI 10.3390/medicina61071160 PMID 40731790 7 citations (OpenAlex) Open-access full textSource: OpenAlex

  10. Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival

    Journal of bone oncology, 2025

    DOI 10.1016/j.jbo.2025.100730 PMID 41399765 Open-access full textSource: OpenAlex

View all 43 publications